SCHEMBL3770652

SCHEMBL3770652

O=Cc1c(F)cc2ccccc2c1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 6/20 0.43
PADI4 Q9UM07 1/20 0.38
HPRT1 P00492 1/20 0.37
CYP1A2 P05177 3/20 0.37
MAPT P10636 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2A6 P11509 3/20 0.36
ALDH1A1 P00352 4/20 0.35
CYP1B1 Q16678 2/20 0.35
HSD17B10 Q99714 2/20 0.35
HIF1A Q16665 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP1A1 P04798 1/20 0.35
HTT P42858 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23043412 0.81 ERN1 (0.41) ERN1PADI4HPRT1CYP1A2MAPT
SCHEMBL27723147 0.80 ERN1 (0.43) ERN1PADI4HPRT1CYP1A2MAPT
SCHEMBL29388184 0.74 ERN1 (0.57) ERN1PADI4CYP1A2MAPTCYP2C19
SCHEMBL30366616 0.74 HPRT1 (0.45) HPRT1CYP1A2CYP2C19CYP2A6ALDH1A1
SCHEMBL1249585 0.74 HPRT1 (0.45) HPRT1CYP1A2CYP2C19CYP2A6ALDH1A1
SCHEMBL342278 0.74 ERN1 (0.57) ERN1PADI4CYP1A2MAPTCYP2C19
SCHEMBL10348702 0.73 ERN1 (0.55) ERN1PADI4CYP1A2MAPTCYP2C19
SCHEMBL11041721 0.72 ERN1 (0.60) ERN1PADI4HPRT1CYP1A2MAPT
SCHEMBL28462492 0.72 MEN1 (0.44) CYP1A2MAPTCYP2C19CYP2C9ALDH1A1
SCHEMBL1161028 0.72 ERN1 (0.49) ERN1CYP1A2MAPTCYP2A6CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010014541-A2 COMPOSITIONS AND METHODS FOR TREATMENT OF HYPERCHOLESTEROLEMIA ALNARA PHARMACEUTICALS, INC. (US) 2010-02-04 WO disclosed
US-5093371-A Naphthyl ketone inhibitors of cholesterol esterase and their use as hypolipidemic and hypocaloric agents UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 1992-03-03 US disclosed